Hypertrophic Obstructive Cardiomyopathy Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Quantitative Assessment of Hypertrophic Obstructive Cardiomyopathy With Intraoperative Three-dimensional Transesophageal Echocardiography Under Provocative Dobutamine Stress Test
Condition: Hypertrophic Obstructive Cardiomyopathy Interventions: Drug: Pre and post-CPB Drug: Dobutamine Hydrochloride; Drug: Post-CPB Drug: Dobutamine Hydrochloride Sponsor: University Health Network, Toronto Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2021 Category: Research Source Type: clinical trials
